|
1
|
Gourvas V, Dalpa E, Konstantinidou A,
Vrachnis N, Spandidos DA and Sifakis S: Angiogenic factors in
placentas from pregnancies complicated by fetal growth restriction
(Review). Mol Med Rep. 6:23–27. 2012.PubMed/NCBI
|
|
2
|
Hashimoto Y, Kawai M, Nagai S, Matsukura
T, Niwa F, Hasegawa T and Heike T: Fetal growth restriction but not
preterm birth is a risk factor for severe hypospadias. Pediatr Int.
58:573–577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patil M, Panchanadikar TM and Wagh G:
Variation of papp-a level in the first trimester of pregnancy and
its clinical outcome. J Obstet Gynaecol India. 64:116–119. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Conover CA, Boldt HB, Bale LK, Clifton KB,
Grell JA, Mader JR, Mason EJ and Powell DR: Pregnancy-associated
plasma protein-A2 (PAPP-A2): Tissue expression and biological
consequences of gene knockout in mice. Endocrinology.
152:2837–2844. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kong X, Jackman SM and Fant ME: Plac1
(placenta-specific 1) is widely expressed during fetal development
and is associated with a lethal form of hydrocephalus. Birth
Defects Res A Clin Mol Teratol. 97:571–577. 2013.PubMed/NCBI
|
|
6
|
Devor EJ, Gonzalez-Bosquet J, Warrier A,
Reyes HD, Ibik NV, Schickling BM, Newtson A, Goodheart MJ and
Leslie KK: p53 mutation status is a primary determinant of
placenta-specific protein 1 expression in serous ovarian cancers.
Int J Oncol. 50:1721–1728. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu Y, Lin X, Di X, Chen Y, Zhao H and Wang
X: Oncogenic function of Plac1 on the proliferation and metastasis
in hepatocellular carcinoma cells. Oncol Rep. 37:465–473. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koslowski M, Sahin U, Mitnacht-Kraus R,
Seitz G, Huber C and Türeci O: A placenta-specific gene ectopically
activated in many human cancers is essentially involved in
malignant cell processes. Cancer Res. 67:9528–9534. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
ACOG Committee on Practice
Bulletins-Obstetrics: ACOG practice bulletin. Diagnosis and
management of preeclampsia and eclampsia. Number 33, January 2002.
Obstet Gynecol. 99:159–167. 2002.PubMed/NCBI
|
|
10
|
Kappou D, Sifakis S, Androutsopoulos V,
Konstantinidou A, Spandidos DA and Papantoniou N: Placental mRNA
expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2
is altered in pregnancies complicated by preeclampsia. Placenta.
35:718–723. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Androutsopoulos VP and Tsatsakis AM:
Benzo[a]pyrene sensitizes MCF7 breast cancer cells to induction of
G1 arrest by the natural flavonoid eupatorin-5-methyl ether, via
activation of cell signaling proteins and CYP1-mediated metabolism.
Toxicol Lett. 230:304–313. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wagner PK, Otomo A and Christians JK:
Regulation of pregnancy-associated plasma protein A2 (PAPPA2) in a
human placental trophoblast cell line (BeWo). Reprod Biol
Endocrinol. 9:482011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kodama M, Miyoshi H, Fujito N, Samura O
and Kudo Y: Plasma mRNA concentrations of placenta-specific 1
(PLAC1) and pregnancy associated plasma protein A (PAPP-A) are
higher in early-onset than late-onset pre-eclampsia. J Obstet
Gynaecol Res. 37:313–318. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaitu'u-Lino TJ, Hastie R, Cannon P, Lee
S, Stock O, Hannan NJ, Hiscock R and Tong S: Stability of absolute
copy number of housekeeping genes in preeclamptic and normal
placentas, as measured by digital PCR. Placenta. 35:1106–1109.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gentile M, Schifano M, Lunardi S, Nanini
C, Moscuzza F, Sergiampietri C, Ciantelli M, Monacci F, Boldrini A
and Luchi C: Maternal PAPP-A levels at 11–13 weeks of gestation
predict foetal and neonatal growth. Open J Obstet Gynecol.
5:365–372. 2015. View Article : Google Scholar
|
|
16
|
Gaccioli F, Lager S, Sovio U,
Charnock-Jones S and Smith GCS: The pregnancy outcome prediction
(POP) study: Investigating the relationship between serial prenatal
ultrasonography, biomarkers, placental phenotype and adverse
pregnancy outcomes. Placenta. 59:S17–S25. 2017. View Article : Google Scholar :
|
|
17
|
Giudice I, Benintende G, Di Nicolò AM,
Mangiameli D, Carrara G, Randazzo C, Sapuppo IM and Gulisano A:
Correlation of neonatal weight with maternal serum levels of
pregnancy-associated plasma protein-A during the first trimester of
pregnancy: A retrospective study. J Perinat Med. 43:227–232. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park HJ, Shim SS and Cha DH: Combined
screening for early detection of pre-eclampsia. Int J Mol Sci.
16:17952–17974. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhong Y, Zhu F and Ding Y: Serum screening
in first trimester to predict pre-eclampsia, small for gestational
age and preterm delivery: Systematic review and meta-analysis. BMC
Pregnancy Childbirth. 15:1912015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wagner PK and Christians JK: Altered
placental expression of PAPPA2 does not affect birth weight in
mice. Reprod Biol Endocrinol. 8:902010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Qiu Q, Haider M, Bell M, Gruslin A
and Christians JK: Expression of pregnancy-associated plasma
protein A2 during pregnancy in human and mouse. J Endocrinol.
202:337–345. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kramer AW, Lamale-Smith LM and Winn VD:
Differential expression of human placental PAPP-A2 over gestation
and in preeclampsia. Placenta. 37:19–25. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Muto M, Fujihara Y, Tobita T, Kiyozumi D
and Ikawa M: Lentiviral vector-mediated complementation restored
fetal viability but not placental hyperplasia in Plac1-deficient
mice. Biol Reprod. 94:62016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fant M, Farina A, Nagaraja R and
Schlessinger D: PLAC1 (Placenta-specific 1): A novel, X-linked gene
with roles in reproductive and cancer biology. Prenat Diagn.
30:497–502. 2010.PubMed/NCBI
|
|
25
|
Purwosunu Y, Sekizawa A, Farina A, Wibowo
N, Okazaki S, Nakamura M, Samura O, Fujito N and Okai T: Cell-free
mRNA concentrations of CRH, PLAC1, and selectin-P are increased in
the plasma of pregnant women with preeclampsia. Prenat Diagn.
27:772–777. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zanello M, Sekizawa A, Purwosunu Y, Curti
A and Farina A: Circulating mRNA for the PLAC1 gene as a second
trimester marker (14–18 weeks' gestation) in the screening for late
preeclampsia. Fetal Diagn Ther. 36:196–201. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fant ME, Fuentes J, Kong X and Jackman S:
The nexus of prematurity, birth defects, and intrauterine growth
restriction: A role for plac1-regulated pathways. Front Pediatr.
2:82014. View Article : Google Scholar : PubMed/NCBI
|
